Daiichi Sankyo
Rachael Cairone Lipson has over 20 years of experience in creating and executing corporate and brand communication and PR campaigns. Rachael has worked in various industries, including healthcare, technology, non-profit, professional services, and consumer products. Rachael currently holds the position of Director, Global Oncology Product Communications at Daiichi Sankyo, Inc. Prior to this, they served as the President of Lipson Communications, Inc., where they specialized in internal and external communications strategy, corporate storytelling, message development, traditional PR, thought leadership, and social media management. Rachael has also held roles as Vice President at GCI Health, TellMed Strategies, ACORD, Ogilvy Public Relations, and Senior Account Supervisor at Edelman. Rachael started their career as an Account Executive at Robin Leedy & Associates.
Rachael Cairone Lipson has a Bachelor of Science degree in Journalism from Southern Connecticut State University.
This person is not in any offices
Daiichi Sankyo
21 followers
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.